NCT06115681View on ClinicalTrials.gov

Real-world Study of Dedifferentiated Liposarcoma Patients in China

CompletedOBSERVATIONAL
Enrollment

1,390

Participants

Timeline

Start Date

March 13, 2024

Primary Completion Date

May 15, 2024

Study Completion Date

May 15, 2024

Conditions
Dedifferentiated Liposarcoma
Trial Locations (1)

102208

Beijing Jishuitan hospital, Beijing

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06115681 - Real-world Study of Dedifferentiated Liposarcoma Patients in China | Biotech Hunter | Biotech Hunter